Codexis (CDXS) Non-Current Assets (2010 - 2026)

Codexis (CDXS) recorded quarterly Non-Current Assets of $42.2 million in Q1 2026, down 3.23% quarter-over-quarter from $43.6 million in Q4 2025, and down 4.06% on a YoY basis from $44.0 million in Q1 2025.

Codexis (CDXS) Non-Current Assets (2010 - 2026) Analysis & Trends

Codexis' Non-Current Assets history runs 17 years deep, the most recent figure standing at $42.2 million for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 4.06% year-over-year to $42.2 million; the TTM figure through Mar 2026 stood at $42.2 million (down 4.06% YoY), while the FY2025 annual figure was $43.6 million, up 1.11% from the prior year.
  • Non-Current Assets was $42.2 million for Q1 2026 at Codexis, down from $43.6 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $66.4 million in Q1 2022 to a low of $24.3 million in Q3 2024.
  • Historically, Non-Current Assets has averaged $45.3 million across 5 years, with a median of $43.1 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Non-Current Assets soared 112.45% in 2022, then sank 56.92% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $61.9 million in 2022, then plunged by 53.74% to $28.6 million in 2023, then jumped by 50.57% to $43.1 million in 2024, then rose by 1.11% to $43.6 million in 2025, then retreated by 3.23% to $42.2 million in 2026.
  • The last three Non-Current Assets figures came in at $42.2 million (Q1 2026), $43.6 million (Q4 2025), and $40.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 62,953.78
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 289.41 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 4.56 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 30.30 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 14.75 Bn
9 Abivax 94.37 Bn 94.37 Bn - 39.71 Mn
10 Codexis 236.00 Mn 170.86 Mn 13.18 Mn 42.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 42.17 Mn
Dec 31, 2025 43.58 Mn
Sep 30, 2025 40.62 Mn
Jun 30, 2025 42.37 Mn
Mar 31, 2025 43.95 Mn
Dec 31, 2024 43.10 Mn
Sep 30, 2024 24.28 Mn
Jun 30, 2024 25.88 Mn
Mar 31, 2024 27.03 Mn
Dec 31, 2023 28.62 Mn
Sep 30, 2023 29.18 Mn
Jun 30, 2023 60.07 Mn
Mar 31, 2023 61.62 Mn
Dec 31, 2022 61.88 Mn
Sep 30, 2022 63.81 Mn
Jun 30, 2022 65.40 Mn
Mar 31, 2022 66.39 Mn
Dec 31, 2021 65.46 Mn
Sep 30, 2021 35.65 Mn
Jun 30, 2021 31.42 Mn